These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15313924)

  • 1. Peptides derived from the histidine-proline domain of the histidine-proline-rich glycoprotein bind to tropomyosin and have antiangiogenic and antitumor activities.
    Doñate F; Juarez JC; Guan X; Shipulina NV; Plunkett ML; Tel-Tsur Z; Shaw DE; Morgan WT; Mazar AP
    Cancer Res; 2004 Aug; 64(16):5812-7. PubMed ID: 15313924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histidine-proline-rich glycoprotein has potent antiangiogenic activity mediated through the histidine-proline-rich domain.
    Juarez JC; Guan X; Shipulina NV; Plunkett ML; Parry GC; Shaw DE; Zhang JC; Rabbani SA; McCrae KR; Mazar AP; Morgan WT; Doñate F
    Cancer Res; 2002 Sep; 62(18):5344-50. PubMed ID: 12235005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histidine-proline rich glycoprotein (HPRG) binds and transduces anti-angiogenic signals through cell surface tropomyosin on endothelial cells.
    Guan X; Juarez JC; Qi X; Shipulina NV; Shaw DE; Morgan WT; McCrae KR; Mazar AP; Doñate F
    Thromb Haemost; 2004 Aug; 92(2):403-12. PubMed ID: 15269838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Domain structure and conformation of histidine-proline-rich glycoprotein.
    Borza DB; Tatum FM; Morgan WT
    Biochemistry; 1996 Feb; 35(6):1925-34. PubMed ID: 8639676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatin: a hyaluronan-binding complex from cartilage that inhibits tumor growth.
    Liu N; Lapcevich RK; Underhill CB; Han Z; Gao F; Swartz G; Plum SM; Zhang L; Green SJ
    Cancer Res; 2001 Feb; 61(3):1022-8. PubMed ID: 11221828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
    Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
    Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal active domain and mechanism of action of the angiogenesis inhibitor histidine-rich glycoprotein.
    Dixelius J; Olsson AK; Thulin A; Lee C; Johansson I; Claesson-Welsh L
    Cancer Res; 2006 Feb; 66(4):2089-97. PubMed ID: 16489009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated platelets provide a functional microenvironment for the antiangiogenic fragment of histidine-rich glycoprotein.
    Thulin A; Ringvall M; Dimberg A; Kårehed K; Väisänen T; Väisänen MR; Hamad O; Wang J; Bjerkvig R; Nilsson B; Pihlajaniemi T; Akerud H; Pietras K; Jahnen-Dechent W; Siegbahn A; Olsson AK
    Mol Cancer Res; 2009 Nov; 7(11):1792-802. PubMed ID: 19903770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
    Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
    J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiangiogenic effect of thrombospondin-2 is mediated by CD36 and modulated by histidine-rich glycoprotein.
    Simantov R; Febbraio M; Silverstein RL
    Matrix Biol; 2005 Feb; 24(1):27-34. PubMed ID: 15748999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroblastoma angiogenesis is inhibited with a folded synthetic molecule corresponding to the epidermal growth factor-like module of the follistatin domain of SPARC.
    Chlenski A; Liu S; Baker LJ; Yang Q; Tian Y; Salwen HR; Cohn SL
    Cancer Res; 2004 Oct; 64(20):7420-5. PubMed ID: 15492265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recombinant human RNASET2 glycoprotein with antitumorigenic and antiangiogenic characteristics: expression, purification, and characterization.
    Smirnoff P; Roiz L; Angelkovitch B; Schwartz B; Shoseyov O
    Cancer; 2006 Dec; 107(12):2760-9. PubMed ID: 17109444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The COOH-terminal globular domain of fibrinogen gamma chain suppresses angiogenesis and tumor growth.
    Akakura N; Hoogland C; Takada YK; Saegusa J; Ye X; Liu FT; Cheung AT; Takada Y
    Cancer Res; 2006 Oct; 66(19):9691-7. PubMed ID: 17018627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 27-amino-acid synthetic peptide corresponding to the NH2-terminal zinc-binding domain of endostatin is responsible for its antitumor activity.
    Tjin Tham Sjin RM; Satchi-Fainaro R; Birsner AE; Ramanujam VM; Folkman J; Javaherian K
    Cancer Res; 2005 May; 65(9):3656-63. PubMed ID: 15867360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal transduction in endothelial cells by the angiogenesis inhibitor histidine-rich glycoprotein targets focal adhesions.
    Lee C; Dixelius J; Thulin A; Kawamura H; Claesson-Welsh L; Olsson AK
    Exp Cell Res; 2006 Aug; 312(13):2547-56. PubMed ID: 16769050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and biological activities of recombinant human plasminogen kringle 1-3 produced in Escherichia coli.
    You WK; So SH; Sohn YD; Lee H; Park DH; Chung SI; Chung KH
    Protein Expr Purif; 2004 Jul; 36(1):1-10. PubMed ID: 15177278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of nonpeptidic topomimetics of antiangiogenic proteins with antitumor activities.
    Dings RP; Chen X; Hellebrekers DM; van Eijk LI; Zhang Y; Hoye TR; Griffioen AW; Mayo KH
    J Natl Cancer Inst; 2006 Jul; 98(13):932-6. PubMed ID: 16818857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide.
    Ferrari N; Pfeffer U; Dell'Eva R; Ambrosini C; Noonan DM; Albini A
    Clin Cancer Res; 2005 Jun; 11(12):4610-9. PubMed ID: 15958647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant anthrax toxin B moiety (protective antigen) inhibits angiogenesis and tumor growth.
    Rogers MS; Christensen KA; Birsner AE; Short SM; Wigelsworth DJ; Collier RJ; D'Amato RJ
    Cancer Res; 2007 Oct; 67(20):9980-5. PubMed ID: 17942931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombospondin-1 mimetic peptide inhibitors of angiogenesis and tumor growth: design, synthesis, and optimization of pharmacokinetics and biological activities.
    Haviv F; Bradley MF; Kalvin DM; Schneider AJ; Davidson DJ; Majest SM; McKay LM; Haskell CJ; Bell RL; Nguyen B; Marsh KC; Surber BW; Uchic JT; Ferrero J; Wang YC; Leal J; Record RD; Hodde J; Badylak SF; Lesniewski RR; Henkin J
    J Med Chem; 2005 Apr; 48(8):2838-46. PubMed ID: 15828822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.